These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1078 related articles for article (PubMed ID: 23542406)
21. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865 [TBL] [Abstract][Full Text] [Related]
22. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies. Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302 [TBL] [Abstract][Full Text] [Related]
23. Early experience with multiparametric magnetic resonance imaging-targeted biopsies under visual transrectal ultrasound guidance in patients suspicious for prostate cancer undergoing repeated biopsy. Boesen L; Noergaard N; Chabanova E; Logager V; Balslev I; Mikines K; Thomsen HS Scand J Urol; 2015 Feb; 49(1):25-34. PubMed ID: 24922550 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer. Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate. Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440 [TBL] [Abstract][Full Text] [Related]
26. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL? Pepe P; Garufi A; Priolo G; Pennisi M Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324 [TBL] [Abstract][Full Text] [Related]
27. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study. Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253 [TBL] [Abstract][Full Text] [Related]
28. Location of Prostate Cancers Determined by Multiparametric and MRI-Guided Biopsy in Patients With Elevated Prostate-Specific Antigen Level and at Least One Negative Transrectal Ultrasound-Guided Biopsy. Schouten MG; Hoeks CM; Bomers JG; Hulsbergen-van de Kaa CA; Witjes JA; Thompson LC; Rovers MM; Barentsz JO; Fütterer JJ AJR Am J Roentgenol; 2015 Jul; 205(1):57-63. PubMed ID: 26102380 [TBL] [Abstract][Full Text] [Related]
29. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes. Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001 [TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance. Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939 [TBL] [Abstract][Full Text] [Related]
32. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839 [TBL] [Abstract][Full Text] [Related]
33. Is Prebiopsy MRI Good Enough to Avoid Prostate Biopsy? A Cohort Study Over a 1-Year Period. Lamb BW; Tan WS; Rehman A; Nessa A; Cohen D; O'Neil J; Green JS; Hines JE Clin Genitourin Cancer; 2015 Dec; 13(6):512-7. PubMed ID: 26231912 [TBL] [Abstract][Full Text] [Related]
34. Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial. Tonttila PP; Lantto J; Pääkkö E; Piippo U; Kauppila S; Lammentausta E; Ohtonen P; Vaarala MH Eur Urol; 2016 Mar; 69(3):419-25. PubMed ID: 26033153 [TBL] [Abstract][Full Text] [Related]
35. Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Renard-Penna R; Mozer P; Cornud F; Barry-Delongchamps N; Bruguière E; Portalez D; Malavaud B Radiology; 2015 May; 275(2):458-68. PubMed ID: 25599415 [TBL] [Abstract][Full Text] [Related]
36. [Prebiopsy multiparametric MRI of the prostate: the end of randomized biopsies?]. Belas O; Klap J; Cornud F; Beuvon F; Peyromaure M; Zerbib M; Delongchamps NB Prog Urol; 2012 Sep; 22(10):583-9. PubMed ID: 22920337 [TBL] [Abstract][Full Text] [Related]
37. Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. Mertan FV; Greer MD; Shih JH; George AK; Kongnyuy M; Muthigi A; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B J Urol; 2016 Sep; 196(3):690-6. PubMed ID: 27101772 [TBL] [Abstract][Full Text] [Related]
38. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235 [TBL] [Abstract][Full Text] [Related]
39. Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the Prostate. Ullrich T; Quentin M; Arsov C; Schmaltz AK; Tschischka A; Laqua N; Hiester A; Blondin D; Rabenalt R; Albers P; Antoch G; Schimmöller L J Urol; 2018 Mar; 199(3):691-698. PubMed ID: 28941924 [TBL] [Abstract][Full Text] [Related]
40. 1.5-T magnetic resonance-guided transgluteal biopsies of the prostate in patients with clinically suspected prostate cancer: technique and feasibility. Bodelle B; Naguib NN; Schulz B; Eichler K; Müller C; Hansmann ML; Hammerstingl R; Hübner F; Vogl TJ; Zangos S Invest Radiol; 2013 Jun; 48(6):458-63. PubMed ID: 23385402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]